Enabling personalised diagnosis, treatment, and stratification through whole-body metabolic modelling of an individual’s genome, metabolome, and metagenome.

AVATAR aims to develop a mechanistic computational modeling framework to link genetic variants, metabolism, and environmental factors for personalized medicine in diagnosing and treating metabolic diseases.

Subsidie
€ 1.999.991
2024

Projectdetails

Introduction

The increasing availability of whole-genome sequences will ultimately transform medicine into personalised medicine. To realise this potential, we need to understand which of the millions of genetic variants in a person's genome can alter a phenotype.

Genome-wide Association Studies

Genome-wide association studies (GWAS) have associated many genetic variants with thousands of phenotypic traits. Metabolomics has further informed GWAS. However, these methods do generally not consider the biochemical network connecting genetic variants with the metabolic phenotype.

Extrinsic Factors

Additionally, extrinsic factors, such as diet and the microbiome, also modulate the metabolic phenotype. A computational systems approach is required to untangle this complex interplay.

Project Overview

In AVATAR, I shall develop and apply a novel mechanistic computational modelling framework that will significantly expand cutting-edge computational models of whole-body metabolism. The novel in silico models will mechanistically describe the network of genetic variants, genes, proteins, and biochemical reactions, as well as underlying physiological processes that are influenced by microbial and nutrient metabolism.

Algorithm Development

I shall devise a novel algorithm to predict phenotypically relevant genetic variants based on a person's genome and metabolome. The validated algorithm and the modelling framework shall then be used for two distinct biomedical proof-of-concept studies:

  1. The diagnosis and diet-based treatment of inherited metabolic diseases.
  2. The metabolic pathway-based stratification of individuals with cognitive impairment.

Impact on Precision Medicine

AVATAR will enable novel insights into the genotype-phenotype-environment relationship by enabling systematic mechanism-based analyses of genetic variants, diet, and the microbiome. This ground-breaking, innovative, multidisciplinary project will influence precision medicine by providing a personalisable modelling analysis framework that may ultimately provide a foundation for computer-guided diagnosis and treatment strategies.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.991
Totale projectbegroting€ 1.999.991

Tijdlijn

Startdatum1-4-2024
Einddatum31-3-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERSITY OF GALWAYpenvoerder

Land(en)

Ireland

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling

This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.

€ 1.499.323
ERC Consolid...

Metabolomics-driven Molecular Source Analysis for personalized medicine in children

MeMoSA aims to enhance personalized medicine for children by identifying gastrointestinal metabolite sources through advanced metabolomics and machine learning, improving disease prevention and treatment efficacy.

€ 1.999.763
ERC Starting...

Gut microbiota drug biotransformation as a tool to unravel the mechanisms of metabolic microbiota-host interactions

This project aims to systematically study metabolic interactions between gut microbiota and hosts using drug biotransformation to improve understanding of microbiome-related health variations and drug responses.

€ 1.894.858
ERC Consolid...

Integrated Mechanistic Modelling and Analysis of Large-scale Biomedical Data

INTEGRATE aims to enhance cancer treatment by developing advanced computational models that integrate patient-derived data for improved drug targeting and clinical trial planning.

€ 1.854.546
ERC Starting...

Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species

This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.

€ 1.499.980

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction

TargetMI aims to rapidly discover novel drug targets and biomarkers for myocardial infarction using a high-throughput multi-omic approach on 1000 samples, enhancing clinical risk prediction and translation.

€ 3.999.840